Alcista
$0.50
Precio del escenario
$1.380
-0.432 (-31.34%)Al cierre
SCWorx Corp. is a provider of data content and services related to the repair, normalization and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. The Company has developed and markets health care information technology solutions and associated services that enhance healthcare processes and information flow within hospitals and other healthcare facilities. Its software enables a healthcare provider to simplify and organize its data (data normalization), allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics (big data). Its software modules include virtualized item master file repair, expansion and automation, electronic medical record management, charge description master management, contract management, request for proposal (RFP) automation, integration of acquired businesses, rebate management, and data integration and warehousing.
Scworx Corp (WORX) is not a good buy right now due to significant losses and declining performance metrics. The current price is $3.73, with a staggering year-to-date change of -89.79%. Additionally, the RSI is at a very low 7.101, indicating extreme oversold conditions, but this could also suggest continued downward pressure. The gross margin has improved to 45.53% in Q4 2025, but the company is still facing substantial net losses, with a net income of -749182 USD in the same quarter. The main risk is the ongoing negative sentiment reflected in the stock's performance, with a 5-day change of -81.04%.
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

SCWorx Enters Two-Year Agreement with Major Massachusetts Healthcare Network

SCWorx Enters Two-Year Agreement with Major Massachusetts Healthcare Network

SCWorx Receives Partial Compliance Letter from Nasdaq

SCWorx Receives Partial Compliance Letter from Nasdaq

SCWorx Launches AI-Assisted Data Management Model to Enhance Healthcare Supply Chain
SCWorx Corp. is a provider of data content and services related to the repair, normalization and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. The Company has developed and markets health care information technology solutions and associated services that enhance healthcare processes and information flow within hospitals and other healthcare facilities. Its software enables a healthcare provider to simplify and organize its data (data normalization), allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics (big data). Its software modules include virtualized item master file repair, expansion and automation, electronic medical record management, charge description master management, contract management, request for proposal (RFP) automation, integration of acquired businesses, rebate management, and data integration and warehousing. It operates in the Industrials sector (SERVICES-MISCELLANEOUS AMUSEMENT & RECREATION industry).
Scworx Corp (WORX) is not a good buy right now due to significant losses and declining performance metrics. The current price is $3.73, with a staggering year-to-date change of -89.79%. Additionally, the RSI is at a very low 7.101, indicating extreme oversold conditions, but this could also suggest continued downward pressure. The gross margin has improved to 45.53% in Q4 2025, but the company is still facing substantial net losses, with a net income of -749182 USD in the same quarter. The main risk is the ongoing negative sentiment reflected in the stock's performance, with a 5-day change of -81.04%.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.